Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/16/2012US8288430 Spiro(5.5)undecane derivatives
10/16/2012US8288429 2-aza-bicyclo[3.3.0]octane derivatives
10/16/2012US8288428 Compounds as cannabinoid receptor ligands
10/16/2012US8288427 Methods of treating emesis using growth hormone secretagogues
10/16/2012US8288425 Benzimidazoles
10/16/2012US8288424 Substituted tetrahydroimidazopyridine compounds and the use thereof in the treatment of pain and other conditions
10/16/2012US8288423 FXa inhibitors with cyclic amidines as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
10/16/2012US8288421 Phenylaminopyridines
10/16/2012US8288420 Compounds capable of activating cholinergic receptors
10/16/2012US8288419 Aminopyrazole derivatives
10/16/2012US8288418 Benzimidazole derivatives and their use for modulating the GABAA receptor complex
10/16/2012US8288417 N-substituted piperidines and their use as pharmaceuticals
10/16/2012US8288416 Substituted piperidinophenyl oxazolidinones
10/16/2012US8288415 For reducing levels of tumor necrosis factor alpha in mammals; 3-(3-Nitrophthalimido)-3-methylpiperidine-2,6-dione; 1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)-5-nitroisoindoline
10/16/2012US8288414 Deuterium-enriched lenalidomide
10/16/2012US8288413 Benzimidazolones which have activity at M1 receptor
10/16/2012US8288412 Psychological disorders; cognition activators
10/16/2012US8288411 Pyrrolidines and piperidines as orexin receptor antagonists
10/16/2012US8288410 3-substituted quinolinium and 7H-indolo[2,3-c]quinolinium salts as new antiinfectives
10/16/2012US8288409 Quinolizidinone M1 receptor positive allosteric modulators
10/16/2012US8288408 5-anilinoimidazopyridines and methods of use
10/16/2012US8288407 Substituted naphthyridine compounds as inhibitors of Akt activity
10/16/2012US8288406 Hydroxymethylcyclohexylamines
10/16/2012US8288405 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
10/16/2012US8288404 Pyrrolidine GPR40 modulators
10/16/2012US8288403 Heterocyclic gamma secretase modulators
10/16/2012US8288402 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
10/16/2012US8288401 Polymorphic forms
10/16/2012US8288400 Compositions useful as inhibitors of protein kinases
10/16/2012US8288399 Medicine containing pyrimidine derivative
10/16/2012US8288398 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones
10/16/2012US8288397 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1
10/16/2012US8288396 Pyrimidopyrimidoindazole derivative
10/16/2012US8288391 Epithelial Sodium Channel and Acid Sensitive Ion Channel modulators; blocking or enhancing salt and sour tastes; additives in chocolate, ice cream, beverages, candies, or pet foods; side effect reduction
10/16/2012US8288390 Benzofuran derivatives
10/16/2012US8288389 Piperazine derivative having affinity for the histamine H3 receptor
10/16/2012US8288388 3-pyridylcarbonyl-piperazinylsulfonyl derivatives
10/16/2012US8288387 Napthalimide-benzimidazole hybrids as potential antitumor agents and process for the preparation thereof
10/16/2012US8288386 Melanocortin receptor agonists
10/16/2012US8288385 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
10/16/2012US8288384 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
10/16/2012US8288383 3-methyl-2- ( (2S) -2- (4- (3-methyl-L, 2, 4-oxadiazol-5-YL) phenyl) morpholino) -6- (pyrim-idin-4-yl) pyrimidin-4 (3H) -one as tau protein kinase inhibitor
10/16/2012US8288382 Diaminothiazoles useful as Axl inhibitors
10/16/2012US8288381 N-9 substituted purine compounds, compositions and methods of use
10/16/2012US8288380 Thiophenediamine derivative having urea structure
10/16/2012US8288379 Thia-triaza-cyclopentazulenes
10/16/2012US8288378 Phosphoinositide modulation for the treatment of neurodegenerative diseases
10/16/2012US8288377 Inhibitors of the interaction between MDM2 and p53
10/16/2012US8288376 Tricyclic N-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
10/16/2012US8288374 Medicinal composition containing benzo[a]phenoxazine compound as the active ingredient for prevention or treatment of protozoal disease
10/16/2012US8288373 Modulators of CXCR7
10/16/2012US8288372 Method for treating headache with loxapine
10/16/2012US8288371 Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
10/16/2012US8288370 Substituted azetidine compounds of formula (I) useful in the treatment of functional gastrointestinal disorders, IBS, and functional dyspepsia
10/16/2012US8288369 Delta-tocotrienol treatment and prevention of pancreatic cancer
10/16/2012US8288368 inhibitors of the C5a induced chemotaxis; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, rheumatoid arthritis and in the prevention and the treatment of injury caused by ischemia and reperfusion
10/16/2012US8288367 Substituted estratriene derivatives as 17BETA HSD inhibitors
10/16/2012US8288366 Formulation for hair growth
10/16/2012US8288365 Phenazopyridine compounds
10/16/2012US8288364 Botanically derived composition and a process thereof
10/16/2012US8288363 Medicaments for anti-herpes virus treatments
10/16/2012US8288362 Stabilized glycosaminoglycan preparations and related methods
10/16/2012US8288361 Pharmaceutical compositions for the treatment of ulcerations
10/16/2012US8288360 Method of treating vitamin B12 deficiency
10/16/2012US8288359 Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
10/16/2012US8288357 Use of inhibitors of leukotriene B4 receptor BLT2 for treating human cancers
10/16/2012US8288356 MicroRNAs
10/16/2012US8288354 Natural antisense and non-coding RNA transcripts as drug targets
10/16/2012US8288353 Method for restructuring the epidermis using a polyol-glycoside composition
10/16/2012US8288317 Liquid crystal agrochemical formulations
10/16/2012US8288139 Sulfotransferase inhibitors
10/16/2012US8287926 Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions
10/16/2012US8287923 Compositions and methods for treating immune disorders
10/16/2012US8287918 Medicament for treating lung cancer
10/16/2012US8287910 Polymeric micelles for polynucleotide encapsulation
10/16/2012US8287904 Stable soft capsule dosage form for acetylsalicylic acid
10/16/2012US8287901 Wound healing compositions based on cyanoacrylates and 5,5-disubstitutedhydantoins, including phenytoin
10/16/2012US8287898 Compositions and methods for body weight management
10/16/2012US8287897 Bitterness-masking particulate jelly beverage
10/16/2012US8287894 Hyaluronan as a drug pre-sensitizer and chemo-sensitizer in the treatment of disease
10/16/2012US8287889 Freeze-dried lecithin nanometer powder injection of ursolic acid and its preparation method
10/16/2012US8287888 Thermosensitive polyphosphazene-bioactive molecule conjugates, preparation method thereof and use thereof
10/16/2012US8287857 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
10/16/2012US8287849 Biodegradable poly(beta-amino esters) and uses thereof
10/16/2012US8287848 Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
10/16/2012US8287847 Administering potassium binding polymer of alpha-fluoroacrylic acid comprising counterion of calcium crosslinked with divinylbenzene, (m)ethylenebisacrylamide, N,N'-bis(vinylsulfonylacetyl) ethylene diamine, 1,3-bis(vinylsulfonyl) 2-propanol, vinylsulfone, polyvinyl ether, polyallylether; hyperkalemia
10/16/2012US8287846 Cosmetic or dermatological preparations comprising N-acetylcysteine
10/16/2012CA2714757C Low viscosity liquid polymeric delivery system
10/16/2012CA2697077C 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
10/16/2012CA2685310C Crystalline and pure modafinil, and process of preparing the same
10/16/2012CA2685230C Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
10/16/2012CA2683341C Hemorrhoid treatment pad
10/16/2012CA2670103C Inhibitors of hiv replication
10/16/2012CA2648594C Solid oral dosage form containing an enhancer
10/16/2012CA2605680C Substituted amide derivatives as protein kinase inhibitors
10/16/2012CA2601715C Dosage regimen for the treatment of a traumatic brain injury with progesterone
10/16/2012CA2600195C Combinations for the treatment of cancer
10/16/2012CA2597740C Modified-release preparations containing oxcarbazepine and derivatives thereof
10/16/2012CA2594171C 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
10/16/2012CA2589229C 9,10-secopregnane derivatives and medicine
1 ... 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 ... 7860